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ABSTRACT 
Background: Human Papillomavirus (HPV) is a prerequisite for the development of 
cervical cancer which is the fourth most common cancer affecting women worldwide. The 
use of HPV vaccine has been found to be responsible for significant decline in the 
prevalence of HPV infection and consequently, of cervical cancer. This study assessed the 
knowledge of HPV and the uptake of HPV vaccine among female undergraduate students 
of Ambrose Alli University, Ekpoma, Nigeria.  
 
Methods: This institution-based cross-sectional study was carried out among 229 
students selected using multi-staged sampling technique. A structured, pretested, self-
administered questionnaire was used to collect data. IBM SPSS version 21.0 was used 
for data analysis. Statistical significance was set at p-value less than 0.05. 
 
Results: Only 12 (5.2%) students were knowledgeable about HPV and 39 (17.0%) were 
aware of the existence of HPV vaccines. The participants’ age (p = 0.031) and level of 
study (p = 0.026) were significantly associated with knowledge of HPV. Only 1 (0.44%) 
student had received the vaccine. Eight (10.8%) students had their sexual debut at 10 to 
14 years, 9 (12.1%) had more than five sexual partners and 21 (23.4%) never used 
condom during sexual intercourse. 
 
Conclusion: The knowledge about HPV infection and uptake of HPV vaccine were very 
low in this study. Concerted effort should be made by health authorities to create 
awareness about HPV infection and its vaccine among university students. This will 
improve HPV vaccine uptake, prevent HPV infections and reduce the prevalence of 
cervical cancer.  
 
Correspondence to:  
Prof. A. R. Isara 
Email: mansaray2001@yahoo.zcom 
Phone number: 08034057565  
 
INTRODUCTION 
Human papillomavirus (HPV) is the most 
common viral infection of the reproductive 
tract globally and most sexually active 
women and men will be infected at some 
point in their lives.1 Human papillomavirus 
is sexually transmitted and most infections 
are usually acquired shortly after becoming 
sexually active. Human papillomavirus 
infection is well recognized as the cause of 
nearly all cases of cervical cancer but 
infection with certain types of HPV also 
causes a proportion of cancers of the anus, 
vulva, vagina, penis and head and neck 
oropharynx.1 Human papillomavirus is also 
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responsible for an important fraction of 
head and neck cancer.2  
More than 100 serotypes of HPV exist, and 
are classified as low risk and high risk. 
Thirty of these target the genitalia and 
approximately 15 types are cancer-causing 
(high risk HPV). It is estimated that about 
three out of four people have HPV at some 
point in their lives and by the age of 50 
years, at least 80 percent of women will have 
acquired the HPV infection.1,3,4 Persistent 
infection with high-risk HPV subtypes 16 
and 18 have been established to be 
responsible for about 70% of all cervical 
cancer cases worldwide.5 Human papillo-
mavirus infection is most prevalent in the 
younger population with the highest rate in 
the age range of 20 to 30 years which 
include many undergraduate university 
students.6,7 About 23.7% of women and 
73% of men in the general population in 
Nigeria carry an HPV genital infection and 
within the first three years of sexual debut, 
50% of women have evidence of an HPV 
infection.5 
Cervical cancer is ranked as the fourth most 
frequently diagnosed cancer and the fourth 
leading cause of cancer death in women 
with an estimated 570,000 cases and 
311,000 deaths in 2018 worldwide.8 It is the 
second most common cancer in women 
living in less developed regions of the world.1 
The development of cervical cancer is a 
multi-stage process that occurs over many 
years and begins when a woman gets 
infected with an oncogenic type of the HPV. 
In Nigeria, cervical cancer ranks as the 
second most common cancer in women aged 
15 to 44 years with about 14,943 new cases 
diagnosed annually.5 It is the second leading 
cause of cancer mortality in the country.9 
These statistics are indicative of a very high 
burden of disease in a country where the 
population at risk for cervical cancer 
(females aged 15 years and above) is 
estimated to be 53.1 million.5 
Cervical cancer can be prevented through 
the use of specific interventions such as 
health education (on delayed sexual debut, 
practice of safe sex, benefits of HPV 
vaccination) and prophylactic vaccination 
against HPV. It can be completely cured 
when diagnosed early after the use of 
screening methods such as Papanicolaou 
(Pap) smear test. Unfortunately, the uptake 
of both HPV vaccination and cervical 
screening services are still rudimentary in 
Nigeria.10 It is recommended that girls aged 
9 to 15 years should be given a two-dose 
regime schedule of HPV vaccine with a 
6-month interval between the doses (0, 6 
months) before they become sexually active 
while women aged 16 to 26 years can be 
given a 3-dose regime (0, 1, and 6 months 
or 0, 2, and 6 months), with cervical cancer 
screening still necessary after HPV 
vaccination.2 With the HPV vaccination 
already available as the primary preventive 
method against cervical cancer one expects 
a decline in HPV infections. However, 
despite the strides made in HPV vaccination 
and education, over half a million women 
worldwide develop cervical cancer each year 
and over 85% of these cases occur in 
developing countries due to the lack of 
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effective screening and prevention 
programmes.10 
The launch of HPV vaccine in Nigeria was 
done in 2009, yet more than a decade after, 
the knowledge of HPV as the causative agent 
of cervical and HPV vaccination as a 
preventive measure against cervical cancer 
including the uptake of vaccination by the 
target population of young people is still 
abysmally low. Many studies carried out 
among female students in secondary 
schools and universities in Nigeria have 
alluded to this fact.11-15 In a similar way, 
parents and caregivers of young people have 
demonstrated poor knowledge of cervical 
cancer prevention and screening for their 
children in Nigeria.16,17 The deficiency of 
such knowledge may adversely affect the 
acceptability and uptake of HPV vaccine. In 
addition, the availability and affordability of 
HPV vaccines is also inimical to the uptake 
HPV vaccine. Presently in Nigeria, HPV 
vaccines are only available in private health 
facilities and at a cost many Nigerians 
cannot afford.18 Efforts that are however 
being made by the Nigerian government to 
include the HPV vaccine as part of national 
routine immunization is rather slow. 
University undergraduate students are a 
special population at risk of cervical cancer. 
Apart from the fact that most of them are 
adolescents, some of them may be living 
independently for the first time. This so 
called freedom may expose them to indulge 
in activities which include but not limited to 
sexual exposures that is capable of 
predisposing them to HPV infection and 
cervical cancer in future, especially if they 
have not been vaccinated against HPV 
infection. Therefore, to promote the 
awareness and knowledge of HPV infection 
and HPV vaccination among university 
students and to add to the body of evidence 
of efforts towards reducing the burden of 
cervical cancer in Nigeria, this study was 
carried out to assess the knowledge of 
human papilloma virus and uptake of HPV 
vaccine among female undergraduate 




The study was carried out at the Ambrose 
Ali University Ekpoma, Edo State, Nigeria in 
December 2017. The university was 
founded in 1981 and was known as Bendel 
State University (BENSU). It became known 
as Edo State University (EDSU) upon the 
creation of Edo and Delta States from the 
defunct Bendel State in 1991, and then 
renamed again as Ambrose Alli University in 
1999 after the founder and former Governor 
of the defunct Bendel State, Professor 
Ambrose Folorunsho Alli. The university has 
12 faculties offering undergraduate and 
postgraduate programmes to full time and 
part time students. As at the time of the 
study, there were 15,786 female students in 
the university. 
Study design and population 
This institution-based descriptive cross-
sectional study was conducted among full 
time female undergraduate students of the 
university. Postgraduate and part time 
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undergraduate students were excluded from 
the study. 
Sample size calculation and sampling 
The minimum sample size required for the 
study which was calculated using the 
formula for single proportions (n= z2pq/d2) 
in a cross-sectional study.19 The following 
assumptions were made at 95% confidence 
interval: the estimate of the expected 
proportion (p) of 14.4% being the proportion 
of female students who were aware of HPV 
vaccine in the University of Lagos, Nigeria,15 
and a desired level of absolute precision (d) 
of ± 5%. Thus the final sample size 
calculated for this study was 212. 
A multi-staged sampling technique was 
used to recruit the participants for the study 
as follows: In the first stage, one department 
in each of the 12 faculties was selected by 
simple random sampling technique. The 
selected departments were: Agricultural 
Economics, History and International 
Studies, Medical Laboratory Science, 
Medicine, Vocational and Technical 
Education, Fine and Applied Arts, Chemical 
Engineering, Botany, Law, Business 
Administration, Chemistry, and Library and 
Information Science. In stage two, a simple 
random sampling technique was used to 
select one academic level of study in each of 
the selected departments. In the third stage, 
participants were recruited from each level 
using a systematic random sampling 
technique. The class list for the particular 
level in the selected department obtained 
from the Head of Department was used as 
the sampling frame and the sampling 
interval (k) was calculated using the 
following formulae,   where k is the 
sampling interval, N is the population of 
female students in the department, and n is 
the number of study participants allocated 
to the faculty. The first study participant 
was selected by simple random sampling 
within the sampling interval for that faculty 
and subsequently every kth student on the 
list was recruited until the size allocated to 
that faculty is reached. A proportional 
allocation according to the total number of 
female students in the respective faculties 
was done to determine the number of 
students that participated in each faculty.  
Data collection and analysis 
A structured, pretested, self-administered 
questionnaire was the tool for data 
collection in this study. The questionnaire 
contained questions on the socio-
demographic profile of the students, their 
knowledge of HPV, awareness of the 
existence of HPV vaccine and the uptake of 
HPV vaccine. 
Data collected were screened for 
completeness, coded and analyzed using 
IBM SPSS version 21.0 (IBM Corp, Armonk, 
NY, USA). An initial univariate analysis was 
carried out to assess the distribution of the 
variables. Sexual activity in this study was 
taken as prior exposure to a penetrative 
sexual intercourse. This is because one 
singular act of penetrative sexual 
intercourse is enough to contract HPV 
infection. Uptake of HPV vaccination was 
defined as having received at least one dose 
of HPV vaccine. 
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Chi-square statistical tests was used to test 
the association between the socio-
demographic characteristics of the students 
and their knowledge of HPV. A composite 
scoring was done for the purpose of the 
bivariate analysis. Knowledge of HPV was 
assessed using ten questions which covers 
the folowing areas: awareness of HPV 
infection, mode of transmission of HPV, 
whether HPV can cause cervical cancer and 
how HPV infection can be prevented. A 
correct answer to each question was given a 
score of “1” while an incorrect answer was 
scored zero. The total score was converted to 
percentage and classified thus: poor level of 
knowledge was a score of less than 50.0%, 
and good level of knowledge was a score of 
50.0% and above. A p value less than 0.05 
was considered as statistically significant. 
Ethical consideration 
Ethical approval for the study was obtained 
from the Health Research Ethics Comm-
ittee, Ambrose Alli University (Protocol 
number 009/17). The management of 
Ambrose Alli University also gave 
permission for the study. Verbal informed 
consent was also obtained from the 
students after full assurance of confidential-
lity before data collection.  
RESULTS 
A total of 229 female undergraduate 
students participated in the study. Their 
ages ranged from 16 to 32 years with a mean 
age of 21 ± 2.5 years. Most of the students 
223 (97.4%) were Christians and almost all 
of them 228 (99.6%) were single. A higher 
proportion of them 139 (60.7%) were in 400 
level of study, followed by 72 (31.4%) in 200 
level while 18 (7.9%) were in 300 level. Over 
two thirds of both parents of the students 
had tertiary level of education (Table 1).  
Table 2 shows the prevalence of risk factors 
for HPV infection among the students. 
About one third (32.3%) were sexually 
active. Among the sexually active students, 
slightly more than half (52.7%) had their 
sexual debut at 15 to 19 years of age. Eight 
(10.8%) and 27 (36.5%) had their sexual 
debut at 10 to 14 years and 20 years and 
above respectively. The mean age at 
coitache was 18.5 ± 3.0 years while the 
modal age at coitache was 18.0 years. Two-
thirds of the students (67.6%) reported 
having only one sexual partner while 9 
(12.1%) had more than five sexual partners. 
On the use of condom during sexual 
intercourse, a higher proportion 32 (43.2%) 
reported occasional use while 21 (23.4%) 
never used condom during sexual 
intercourse. 
The different domains of knowledge of HPV 
infection is shown in Table 3. Less than half 
(47.6%) of the students had heard of HPV 
infection. One hundred and three (45.0%) 
and 101 (44.1%) knew that HPV was a viral 
infection and is sexually transmitted, 
respectively. Only 81 (35.4%) knew that HPV 
can cause cervical cancer while 84 (36.7%) 
affirmed that HPV infection can be 
prevented by vaccination. The overall 
composite score of the knowledge of HPV 
showed that only 34 (14.8%) had good 
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1: Socio-demographic characteristics of 
respondents 
Variables Frequency (n = 
229) 
Percent 
Age (years)   
16 – 19 49 21.4 
20 – 24 159 69.4 
25 – 29 18 7.9 
30 – 32 







Christianity 223 97.4 







Single 228 99.6 




200 72 31.4 
300 18 7.9 
400 139 60.7 
 
Father’s level of 
education 
  
Primary 7 3.1 
Secondary 47 20.5 
Tertiary 175 76.4 
 
Mother’s level of 
education 
  
Primary 23 10.0 
Secondary 53 23.1 
Tertiary 153 66.8 
Age range - 16 to 32 years 
 
Table 4 showed the association between the 
socio-demographic characteristics of the 
students and their knowledge of HPV. There 
was an increase in knowledge of HPV with 
increasing age and increasing level of study.    
This association was statistically 
significant, p = 0.031 and p = 0.026, 
respectively. Although, the students whose 
parents had tertiary level of education were 
more knowledgeable about HPV, the 
association between the parents’ level of 
education and the students’ knowledge of 
HPV was not statistically significant. 
When asked of their awareness of HPV 
vaccines, only 39 (17.0%) of the students 
affirmed that they were aware of the 
existence of HPV vaccines. Majority of the 
students 190 (83.0%) were not aware that 
there is a vaccine against HPV infection. 
Among those who were aware of HPV 
vaccines, the major sources of information 
about HPV vaccines as stated by the 
students were health care workers (41.0%), 
friends (23.1%) and social media/internet 
(23.1%). Only 1 (2.6%) student got 
information from a sibling. Overall, only one 
student (0.4%) reported to have received the 
HPV vaccine prior to the study (Table 5). 
DISCUSSION 
It is no accident that HPV infection, and by 
implication cervical cancer, both of which 
are preventable, still continuously 
dominates as leading cause of morbidity 
and mortality in many sub-Saharan 
countries including Nigeria. This study 
demonstrated a very poor knowledge of HPV 
infection as a cause of cervical cancer and a 
near zero uptake of HPV vaccine among the 
female undergraduate students studied. 
This finding in a tertiary institution among 
young literate women in the prime of their 
lives is an indication that the situation may 
be worse in the general population 
considering the high number of young 
women who do not have the opportunity to 
attain tertiary level of education in Nigeria.  
In this study, only 14.8% of the students 
were knowledgeable about HPV being the 
cause of cervical cancer. This poor 
knowledge is comparable to the 11.1% 
reported in a study among university 
students in Lagos, Nigeria15 and in others 
countries of the world like Ghana (7.9%),20 
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Table 2: Risk factors for HPV infection among the respondents  
Variable                                                        Frequency             Percent    
Sexual activity (n = 229) 
Yes                                                                   74                          32.3                   
No                                                                  155                          67.7 
 
Age at coitache in years* (n = 74) 
10 – 14                                                              8                          10.8                 
15 – 19                                                            39                          52.7  
≥ 20                                                                 27                          36.5 
 
Number of sexual partners (n = 74) 
1                                                             50                          67.6                 
2 - 5                                                                 15                          20.3  
> 5                                                                     9                          12.1 
 
Use of condom (n = 74) 
Always                                                              21                         28.4                   
Sometimes                                                        32                         43.2 
Never                                                                21                         28.4 




Table 3: Knowledge of HPV infection among respondents 
 
Variable                                                                         Frequency (n = 229)     Percent                                              
Have heard of HPV infection                                             109                                   47.6 
HPV is a viral infection                                                     103                                   45.0                   
HPV is a sexually transmitted infection                            101                                   44.1 
Multiple sexual partners predispose to HPV infection         87                                   38.0                    
Weak immune system predisposes to HPV infection           25                                   10.9 
HPV can cause cervical cancer                                           81                                   35.4                 
HPV can cause genital warts                                              58                                   25.3  
HPV infection can cause penile cancer                               37                                   16.2 
HPV infection can be prevented by vaccination                   84                                   36.7 
HPV infection can be prevented by use of condom              50                                   21.8                 
 
 
Table 4: Respondents’ socio-demographic characteristics and knowledge of HPV infection 
 
Variable                                           Knowledge of HPV infection             p-value    
                                                        Good (n=34)           Poor (n=195) 
                                                         n (%)                      n (%)       
Age group in years 
16 – 19                                            1 (2.0)                       48 (98.0)                  0.031* 
20 – 24                                          28 (17.6)                   131 (82.4) 
25 – 29                                            4 (22.2)                     14 (77.8) 
30 – 32                                            1 (33.3)                       2 (66.7) 
 
Level of study 
200                                                  4 (5.6)                       68 (94.6)                  0.026* 
300                                                  3 (16.7)                     15 (83.3) 
400                                                27 (19.4)                   112 (80.6) 
 
Father’s Level of education 
Primary                                           1 (14.3)                       6 (85.7)                  0.901 
Secondary                                       6 (12.8)                     41 (87.2) 
Tertiary                                         27 (15.4)                   148 (84.6) 
 
Mother’s Level of education 
Primary                                           2 (8.7)                        21 (91.3)                 0.678 
Secondary                                       8 (15.1)                      45 (84.9) 
Tertiary                                         24 (15.7)                    129 (84.3) 
*Statistically significant 
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Table 5: Awareness, major source of information and uptake of HPV vaccine 
 
Knowledge Frequency  
 
Percent 










Source of information (n = 39) 
Healthcare workers                                                               
Friends                                                                        
Social media/Internet                                                                  
Television/Radio                                       
Books                                                       
Siblings 
 




















  5.1 
  5.1 
  2.6 
 
   
  0.4 
99.6 
India (15.0%),21 and in a systematic review 
carried out in sub-Saharan African 
countries.22 However, a study in Pakistan 
reported that 55% of university students 
knew that HPV causes cervical cancer.23  
Poor knowledge of HPV infection exhibited 
by young female undergraduate students is 
definitely a potential set back that can 
jeopardize HPV infection and cervical cancer 
prevention control efforts in any population.  
Increasing age and level of study of the 
students were significantly associated with 
knowledge of HPV infections. The Lagos 
study also reported an association between 
a higher level of study and knowledge of 
HPV.15 This finding is quite understandable 
because of the positive correlation between 
age and the level of study of students. Older 
students in higher levels of study would 
have been more exposed to various sources 
of information on HPV in the course of their 
study. The high level of education of the 
parents of the students in this study did not 
show any significant association with the 
knowledge of HPV. This is not surprising 
because studies have shown that many 
parents and caregivers also exhibit poor 
knowledge of HPV and cervical cancer, 13, 17, 
24-26 and so they may not be in the position 
to pass information to their children. This is 
a demonstration of the maxim that “you 
cannot give what you do not have”. But the 
good aspect of this finding is that, it 
underscores the need for activities aimed at 
promoting awareness of HPV and cervical 
cancer to be all-inclusive in terms of its 
target i.e. children, adolescents, young 
people and adult males and females.  
The awareness of the existence of HPV 
vaccines was very poor among the students 
in this study and this also dovetail into the 
near zero uptake of the vaccine by the 
students. Lack of awareness of HPV vaccine 
will impact negatively on the uptake of the 
vaccine. It is not surprising that none of the 
students mentioned their parents as their 
source of information about HPV vaccines. 
This finding underscores the need for 
parents to be educated on their role in the 
fight against HPV infection and cervical 
cancer. Low uptake of HPV vaccines among 
students have also been reported in 
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previous studies in Nigeria such as Lagos 
(2.6%),11 Benin City (3.7%),27 Ibadan 
(4.1%),14 Port Harcourt (5.1%),12 Enugu 
(6.9%),17 and in Lebanon (2.5%)28 and 
Malaysia (3.6%).29 In contrast, a much 
higher uptake was reported in developed 
countries like the United States of America 
(47.3%)30 and Germany (67.0%).31 Other 
factors that militate against HPV vaccine 
uptake in Nigeria as has been documented 
in previous reports include cost and 
availability of vaccines.17,18,32  
It is sad to note that more than a decade 
after the launch of HPV vaccine in Nigeria, it 
is yet to be made readily available to the 
populace at a cost that they can afford. An 
intensive health promotion programme to 
raise awareness about the existence of HPV 
vaccines and its uptake coupled with readily 
available HPV vaccines will go a long way in 
the prevention of HPV infection and cervical 
cancer in Nigeria. A study in northern 
Nigeria revealed that more than 70% of 
female undergraduate students expressed 
willingness to accept HPV vaccine.33 Also, 
majority of mothers and caregivers in 
Nigeria were willing to have their daughters 
vaccinated against HPV infection.15,17 This 
positive disposition expressed by both 
female students and mothers/caregivers is 
quite encouraging and it can be utilized to 
improve HPV vaccine uptake in the target 
population. 
Some risk factors for HPV infection were 
identified in this study. Among those who 
were sexually active, 10.8% had their first 
sexual intercourse between the ages of 10 
and 14 years. This early sexual exposure 
has serious implications for HPV infection 
especially when about one quarter of the 
students reported that they never used 
condom during sexual intercourse. Early 
exposure to unprotected sexual intercourse 
and multiple sexual partners are major 
determinants of HPV infection. Thus, there 
is need for female children to be educated 
early in life (in primary schools) about risk 
factors for HPV infections and cervical 
cancer and this should culminate in their 
reception of HPV vaccine before they enter 
secondary school. Another worrisome risk of 
HPV infection among young female children 
in Nigeria is the rising incidence of sexual 
assault. This was corroborated by the recent 
United Nations report that there is a 56% 
rise in gender based violence in Nigeria with 
some of these incidents of violence tragically 
resulting in the rape of children, including 
incestual rape.34 Apart from the immediate 
physical and psychological trauma faced by 
female children who are victims of rape, they 
are also exposed to various sexually 
transmitted infections such as human 
immunodeficiency virus (HIV), hepatitis B, 
hepatitis C and HPV infections. The 
infection with HPV will lead to long term 
complication of cervical cancer. Therefore, 
all hands must be on deck in the use of 
preventative measure such as awareness 
promotion and scaled HPV vaccination to 
save female children in particular and the 
entire country in general from the menace 
and burden of HPV infections and cervical 
cancer. The use of a self-administered 
questionnaire without identifiers was 
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adopted to enable the students expressed 
themselves freely without reservation 
because of the sensitive nature of issues of 
sexual and reproductive health in the 
African setting. However, the study may 
have been prone to both information and 
recall biases.  
Conclusion: This study showed that the 
knowledge of HPV infection as a cause of 
cervical cancer was very poor among the 
female undergraduate students studied. 
Despite the considerable proportion of 
students who may be at risk of HPV 
infection, there was an abysmally low 
uptake of HPV vaccination by the students. 
Education on HPV infection and cervical 
cancer should be promoted in all primary, 
secondary and tertiary institutions in the 
country to increase awareness and to serve 
as reinforcement for increased knowledge of 
HPV infection and cervical cancer. Parents 
and caregivers should make conscious effort 
to ensure their children receive HPV 
vaccination before they become sexually 
active. Young girls should be made to show 
evidence of HPV vaccination before they are 
admitted into secondary schools.  
The Federal Government of Nigeria through 
the Federal Ministry of Health and the 
National Primary Health Care Development 
Agency should take urgent steps to 
incorporate HPV vaccine into the routine 
immunization schedule of the country in 
line with the WHO recommendation, so that 
young girls can be immunized against HPV 
infection for free. At worst, government 
should highly subsidize the HPV vaccine to 
drastically reduce the cost so that it is 
conveniently affordable to the huge 
population of low and no-income earners in 
the country. This will help to reduce the 
huge health resource that would have been 
expended on treatment of cervical cancer 
and its complications.  
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